Sadhana nitrochem has announced significant governance developments following regulatory requirements. The company's Board of Directors passed a circular resolution on March 30, 2026, implementing key structural changes in compliance with recent regulatory guidelines.

TCWG Committee Constitution

The company has constituted a committee of Those Charged With Governance (TCWG) pursuant to the National Financial Reporting Authority (NFRA) circular dated January 7, 2026. This committee represents a crucial governance structure designed to enhance oversight and compliance mechanisms.

Nodal Officer Appointment

Simultaneously, the company appointed Mr. Mukul S. Mehra as Nodal Officer pursuant to the NFRA circular dated January 7, 2026. This dual role positions Mr. Mehra as both the committee chairman and the designated point of contact for regulatory compliance matters.

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary Nitin Rameshchandra Jani communicated these developments to both BSE Limited and National Stock Exchange of India Limited on March 30, 2026.

These governance enhancements reflect the company's commitment to maintaining robust compliance frameworks and adhering to evolving regulatory requirements in the Indian financial market.

Sadhana Nitrochem Limited has successfully completed its rights issue process and received trading approval from both BSE Limited and National Stock Exchange of India Limited for 263,52,83,328 equity shares. The company announced on March 16, 2026, that it has received formal trading approval letters from both exchanges, with trading set to commence on March 17, 2026.

Rights Issue Completion and Allotment

The Empowered Rights Issue Committee, duly authorized by the Board of Directors, had earlier approved the allotment of equity shares on March 12, 2026, at 7:00 p.m. The committee's decision came after finalizing the basis of allotment in consultation with the Registrar to the Issue and BSE Limited, which served as the designated stock exchange for the transaction.

Stock Exchange Approvals

Sadhana Nitrochem received formal trading approval from both major Indian stock exchanges on March 16, 2026. BSE Limited issued approval through Letter LOD/RIGHTS/SV/69/2025-2026, while National Stock Exchange of India Limited provided confirmation via Letter NSE/LIST/2026/54054.

Capital Structure Transformation

The rights issue has resulted in a substantial transformation of the company's capital structure, with the paid-up equity share capital expanding significantly:

Regulatory Compliance

The company maintained full regulatory compliance throughout the process, making disclosures in accordance with Regulation 30 and 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Earlier, on March 15, 2026, the company had published basis of allotment advertisements in Financial Express, Jansatta, and Mumbai Lakshadeep newspapers.

The successful completion of the rights issue and receipt of trading approvals positions Sadhana Nitrochem Limited with enhanced financial flexibility and expanded equity participation from its shareholder base, while maintaining full regulatory compliance throughout the process.